Netherlands vs Norway: Share of S. aureus infections resistant to methicillin
Netherlands
2.3%
in 2022
Norway
0.9%
in 2021
Netherlands rank
42nd
Norway rank
45th
Share of S. aureus infections resistant to methicillin over time
- Netherlands
- Norway
How they compare
Netherlands currently reports 2.3% against 0.9% in Norway, a difference of 1.4%.
That makes Netherlands's figure about 2.5 times Norway's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Netherlands ahead.
Netherlands ranks 42nd and Norway ranks 45th of 45 countries.
Netherlands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Netherlands | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.1% | 0.4% | Netherlands |
| 2020s | 1.6% | 1.5% | 0.1% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Netherlands or Norway?
- Netherlands, at 2.3% against 0.9% in Norway as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Netherlands and Norway?
- 1.4%, with Netherlands ahead.
- How many years of comparable data are there for Netherlands and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Netherlands and Norway rank globally for share of s. aureus infections resistant to methicillin?
- Netherlands ranks 42nd and Norway ranks 45th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).